Cell cycle dysregulation in pituitary oncogenesis

Area of Science:

• Molecular Biology
• Cell Biology
• Oncology

Background:

• The cell cycle control system, comprising cyclins, cyclin-dependent kinases (CDKs), and cyclin-dependent kinase inhibitors (CDKIs), regulates cell growth, genome replication, and division.
• Loss of cell cycle regulation, especially at the G1/S transition, is a common hallmark of human tumors, including pituitary tumors.
• Key regulators like the p53 family and securin (PTTG) play critical roles in maintaining genomic stability and cell cycle control.

Purpose of the Study:

• To investigate the role of cell cycle regulators, particularly p27, in the pathogenesis of pituitary tumors.
• To explore the mechanisms of p27 dysregulation, including post-translational modifications, degradation, and cellular compartmentalization, in pituitary tumors.
• To identify potential therapeutic targets by understanding the aberrant cell cycle control in pituitary oncogenesis.

Main Methods:

• Analysis of p27 protein expression and localization in human pituitary tumor samples and normal pituitary tissue.
• Investigation of post-translational modifications of p27, such as phosphorylation at Thr187 and Thr157.
• Assessment of the expression and role of proteins involved in p27 degradation, including Jun-activation binding protein-1 (Jab1), Skp2, Cks1, and Akt.
• Evaluation of pituitary tumor-transforming gene (PTTG) expression in pituitary tumors.

Main Results:

• Reduced p27 protein expression in corticotroph adenomas and pituitary carcinomas compared to normal pituitary tissue, suggesting accelerated nuclear removal.
• Evidence of increased p27 phosphorylation and cytoplasmic retention mediated by Akt in pituitary tumors.
• Dysregulation of p27 degradation pathways, with inverse correlation between p27 levels and Skp2 expression in pituitary tumors.
• Elevated PTTG mRNA and protein levels in the majority of pituitary adenomas.

Conclusions:

• Cell cycle dysregulation, particularly involving p27 protein levels, post-translational modifications, and cellular localization, is a significant factor in pituitary tumor development.
• Aberrant regulation of p27 degradation and nuclear export contributes to pituitary oncogenesis.
• PTTG overexpression is common in pituitary adenomas, suggesting its involvement in tumor formation.
• Understanding these regulatory mechanisms offers potential avenues for therapeutic intervention in pituitary tumors.